[1] |
陈丹,钱家鸣.慢性活动性EB病毒感染[J].胃肠病学和肝病学杂志,2016,25(10):1193-1197.
|
[2] |
王小艺,岑溪南,任汉云,等.淋巴瘤患者EBV感染状态的调查[J].中国实验血液学杂志,2014,22(6):1584-1590.
|
[3] |
李敏,高子芬.淋巴瘤的病理诊断[J].临床内科杂志.2015,32,(3):152-154.
|
[4] |
石远凯,孙燕,刘彤华,等.中国恶性淋巴瘤诊疗规范(2015 年版)[J].中华肿瘤杂志,2015,37(2):148-158.
|
[8] |
刘文硕,南飞飞,贾思思,等.结外NK/T细胞淋巴瘤检测EB病毒与疗效关系的研究[J].中国肿瘤临床,2015,42(2):105-108.
|
[9] |
张静,岳磊,李颖璐.NK/T细胞淋巴瘤患者外周血EB病毒检测价值分析[J].中国实验血液学杂志,2017,25(2):460-464.
|
[12] |
安娜,谢亚萍,徐颖,等.血浆EB病毒DNA在弥漫大B细胞淋巴瘤中的预后意义[J].中华内科杂志,2017,56(11):839-841.
|
[5] |
Gires O,Zimber-Strol U,Gonnella R,et al.Latent membrane protien 1 of Epstein-Barr virus mimices a constitutively active receptor molecule[J].EMBOJ,1997,16(20):6131-6140.
|
[6] |
Samanta M,lwakiri D,Takada K.Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3signaling[J].Oncogene,2008,27(30):4150-4160.
|
[7] |
Kanakry JA,Hegde AM,Durand CM,et al.The clinical significance of EBV DNAin the plasma and peripheral bloodmononuclear cells of patients with orwithout EBV diseases[J].Blood,2016,127(16):2007-2017.
|
[10] |
Sun L,Zhao Y,Shi H,et al.LMP-1 induces survivin expression to inhibit cell apotosis through the NF-kB and PI13/Akt signaling pathways in nasal NK-T-cell lymphoma[J].Oncol Rep,2015,33(5):2253-2260.
|
[11] |
Gu L,Hong L,Ling Z,et al.Establishment and characterization of a CD20-positive NK/T-cell lymphoma cell line[J].Clin Lab,2015,61(7):731-739.
|
[13] |
Tse E,Kwong YL.The diagnosis and management of NK/T-cell lymphomas[J].J Hematol Oncol,2017,10(1):85.
|
[14] |
Sato A,Nakamura N,Kojima M,et al.Clinical outcome of Epstein-Barr virus-positive diffuse lagre B-cell lymphoma of the elderly in the rituximab era[J].Cancer Sci,2014,105(9):1170-1175.
|
[15] |
周静,肖毅.EB病毒与其相关淋巴瘤的研究进展[J].中国实验血液学杂志,2018,26(1):292-295.
|